You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Humoral Immunodeficiency

Showing 1 - 25 of 1,712
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Deficiency Trial in Charlottesville (Salmonella typhi polysaccharide vaccine)

Recruiting
  • Immune Deficiency
  • Salmonella typhi polysaccharide vaccine
  • Charlottesville, Virginia
    University of Virginia Health System
May 16, 2022

Common Variable Immunodeficiency and Related Syndromes

Recruiting
  • CVID
  • XLA
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Primary Immunodeficiency Trial in United States (Gamunex-C, IVIG-PEG)

    Completed
    • Primary Immunodeficiency
    • Gamunex-C
    • IVIG-PEG
    • Birmingham, Alabama
    • +10 more
    Jun 7, 2022

    Immunologic Deficiency Syndromes Trial in Canada, United States (GC5107)

    Completed
    Has Results
    • Immunologic Deficiency Syndromes
    • GC5107
    • Centennial, Colorado
    • +19 more
    Nov 11, 2022

    Secondary Immune Deficiency Trial in Rochester (20% subcutaneous immunoglobulin)

    Completed
    • Secondary Immune Deficiency
    • 20% subcutaneous immunoglobulin
    • Rochester, New York
      Allergy and Immunology, 222 Alexander Street
    Apr 14, 2021

    Antibody Detection of Vaccine-Induced Secretory Effects

    Active, not recruiting
    • Covid19
    • +3 more
    • SARS-CoV-2 vaccine
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jul 18, 2022

    Primary Immune Deficiency Disorder Trial (Immunoglobulin)

    Withdrawn
    • Primary Immune Deficiency Disorder
    • Immunoglobulin
    • (no location specified)
    Jul 1, 2020

    IgG Subclasses and on Immunity of Secondary Immunodeficiency

    Completed
    • Secondary Immune Deficiency
    • Chalon-sur-Saône, France
    • +5 more
    Feb 28, 2022

    Secondary Immune Deficiency Disorder Trial in Rochester (Hizentra)

    Completed
    • Secondary Immune Deficiency Disorder
    • Rochester, New York
      Allergy, Immunology, Rheumatology at Rochester Regional Health
    Aug 25, 2020

    Humoral Immune Response Trial in United States (Bivigam)

    Recruiting
    • Humoral Immune Response
    • Bivigam
    • Centennial, Colorado
    • +7 more
    Jun 10, 2021

    COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)

    Not yet recruiting
    • COPD Exacerbation Acute
    • CUVITRU - Ig subcutaneous human 20%
    • Standard Medical Therapy
    • Rochester, New York
    • +2 more
    Feb 28, 2023

    HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)

    Recruiting
    • HIV Seropositivity
    • +3 more
    • Blood draw
    • Ghent, East Flanders, Belgium
      UH Ghent
    Jan 4, 2023

    Primary Immunodeficiency Disease Trial (IVIG)

    Not yet recruiting
    • Primary Immunodeficiency Disease
    • IVIG
    • (no location specified)
    Oct 16, 2023

    Composition and Function of Gut Microbiota in Porto-sinusoidal

    Not yet recruiting
    • Common Variable Immunodeficiency
    • Vascular Diseases
    • Stool sample
    • Paris, France
      Immunologie Clinique Hôpital Saint Louis
    Jul 28, 2022

    Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)

    Recruiting
    • Severe Combined Immunodeficiency, X-Linked
    • Lentiviral vector transduced CD34+ cells
    • London, Greater London, United Kingdom
      Great Ormond Street Hospital for Children NHS Foundation Trust
    Mar 15, 2022

    Monkeypox Trial in United States (JYNNEOS)

    Not yet recruiting
    • Monkeypox
    • JYNNEOS
    • San Diego, California
    • +7 more
    Aug 20, 2022

    Primary Immunodeficiency Disease Trial (Boya IVIG)

    Not yet recruiting
    • Primary Immunodeficiency Disease
    • Boya IVIG
    • (no location specified)
    Nov 21, 2023

    COVID-19 Vaccines in Immunocompromised and Healthy Individuals

    Recruiting
    • Covid19
    • Immunosuppression
    • Blood sample
    • Saliva sample
    • Graz, Austria
      Medical University of Graz
    May 9, 2022

    HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))

    Completed
    • HIV Infections
    • HIV Seronegativity
    • gp160 Vaccine (Immuno-AG)
    • Saint Louis, Missouri
    • +1 more
    Oct 28, 2021

    Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

    Not yet recruiting
    • Covid-19 Pandemics
    • Tuberculosis
    • Pfizer-BioNTech COVID-19 vaccine
    • +2 more
    • Mae Sot, Tak, Thailand
      Shoklo Malaria Research Unit (SMRU)
    Oct 21, 2022

    Normal Subjects and Disorders of Immune System and Cancer

    Recruiting
    • T-cell Lymphoma
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Healthy Trial in Worldwide (Ad26.Mos4.HIV, Clade C and Mosaic gp140 HIV bivalent vaccine, Placebo)

      Active, not recruiting
      • Healthy
      • Ad26.Mos4.HIV
      • +2 more
      • Birmingham, Alabama
      • +52 more
      Jan 17, 2023

      Human Immunodeficiency Virus (HIV), AIDS Virus Trial in Silver Spring (A244, B.63521, 50µg ALFQ)

      Not yet recruiting
      • Human Immunodeficiency Virus (HIV)
      • AIDS Virus
      • A244
      • +4 more
      • Silver Spring, Maryland
        Walter Reed Army Institute of Research, Clinical Trials Center
      Jul 20, 2022

      HIV Trial in Boston (F105 Monoclonal Antibody (Human))

      Completed
      • HIV Infections
      • F105 Monoclonal Antibody (Human)
      • Boston, Massachusetts
        Beth Israel Deaconess Med. Ctr., ACTG CRS
      Oct 28, 2021

      Acute Bronchiolitis Due to Respiratory Syncytial Virus Trial in Ghent (V-306 candidate vaccine)

      Completed
      • Acute Bronchiolitis Due to Respiratory Syncytial Virus
      • V-306 candidate vaccine
      • Ghent, Belgium
        Centre for Vaccinology (CEVAC)
      Mar 4, 2022